Literature DB >> 4696606

Desmethylimipramine and the hypotensive action of clonidine in the rabbit.

J L Reid, R H Briant, C T Dollery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4696606     DOI: 10.1016/0024-3205(73)90215-4

Source DB:  PubMed          Journal:  Life Sci I        ISSN: 0300-9653


× No keyword cloud information.
  8 in total

1.  Clonidine mydriasis in the cat. Further evidence for a CNS postsynaptic action.

Authors:  M C Koss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

2.  Lack of interaction between the tetracyclic antidepressant maprotiline and the centrally acting antihypertensive drug clonidine.

Authors:  U Gundert-Remy; E Amann; R Hildebrandt; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Evidence for a central postsynaptic action of clonidine.

Authors:  M C Koss; H D Christensen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-05       Impact factor: 3.000

4.  The effects of desmethylimipramine on the pharmacological actions of alpha methyldopa in man.

Authors:  J L Reid; A J Porsius; C Zamboulis; G Polak; C A Hamilton; C R Dean
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

5.  Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients.

Authors:  H L Elliott; K McLean; D J Sumner; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Assessment of the interaction between mianserin and centrally-acting antihypertensive drugs.

Authors:  H L Elliott; B Whiting; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

7.  The cardiovascular effects of intraventricular clonidine and Bay 1470 in conscious hypertensive cats.

Authors:  L Finch
Journal:  Br J Pharmacol       Date:  1974-11       Impact factor: 8.739

8.  Pharmacodynamic studies on mianserin and its interaction with clonidine.

Authors:  H L Elliott; K McLean; D J Sumner; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.